Institution

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · PHASE 2 TRIAL

Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer

ClinicalTrials.gov

This is a clinical trial registry record for a planned Phase 2 study with no results posted; it describes the protocol and enrollment target only.

PreliminaryHR+ / HER2 Advanced Breast Cancer NCT07810088 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Reported

Planned enrollment40

Primary outcome measureProgression-free survival, up to 2 years

Study phasePhase 2

AUG 4, 2026 · OBSERVATIONAL STUDY

Correlation of Memory CD8+ T Cells With Sepsis Severity and Mortality: a Single-center, Unblinded, Prospective, Non-interventional, Observational Study

ClinicalTrials.gov

This is a recruiting observational study with no results posted; it aims to correlate memory CD8+ T cell subsets with sepsis outcomes but has not yet reported findings.

PreliminaryNCT05875740 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Inflammatory Response

Reported

Planned enrollment80

Primary outcome measure 1Absolute number of CD8+T subsets in periphe…

Primary outcome measure 2Proliferation of CD8+T subsets in periphera…